New York A 10185: Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug

Status: REFERRED TO INSURANCE (as of 2024-05-10)

State: New York · Session: 2023-2024 · Bill: A 10185

Sponsors: Rules Committee

View New York A 10185 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.